A 62-year-old woman with obstructive jaundice undergoes imaging studies that reveal a distal common bile duct stricture with proximal ductal dilatation. She is being prepared for therapeutic intervention. Regarding the management of distal CBD obstruction, all of the following statements are correct EXCEPT:

Explanation

## Management of Distal CBD Obstruction ### Treatment Hierarchy — Non-Invasive First **Key Point:** Distal common bile duct obstruction is managed using a **stepwise approach**: endoscopic therapy first, percutaneous drainage second, and surgery only after failed endoscopic/percutaneous intervention. ### First-Line Therapeutic Options | Modality | Indication | Success Rate | Advantages | | --- | --- | --- | --- | | **ERCP + sphincterotomy ± stent** | Benign distal CBD obstruction (stones, strictures) | >90% | Minimally invasive, rapid, repeatable | | **PTC ± stent** | Failed ERCP, duodenal obstruction, altered anatomy | 85–95% | Percutaneous access when endoscopic route unavailable | | **Surgical choledochoduodenostomy** | Failed endoscopic/percutaneous therapy, malignancy | Variable | Definitive, but reserved for failed conservative measures | ### Why Surgical Choledochoduodenostomy Is NOT First-Line **High-Yield:** Surgical intervention for distal CBD obstruction is **reserved for failed endoscopic/percutaneous therapy** because: 1. **ERCP success rate >90%** for benign distal strictures and stones — endoscopy should always be attempted first 2. **Lower morbidity** with endoscopic approach (no general anesthesia, faster recovery) 3. **Reversibility** — endoscopic stents can be removed or repositioned; surgical anastomosis is permanent 4. **Cost-effectiveness** — endoscopy is cheaper and faster 5. **Surgical choledochoduodenostomy** carries risks of: - Anastomotic stenosis (10–15% long-term) - Cholangitis from reflux - Duodenal ulceration - Increased morbidity in elderly patients **Clinical Pearl:** Surgery is indicated **only after** failed endoscopic therapy (typically ≥2 failed ERCP attempts) or when endoscopy is anatomically impossible (e.g., Billroth II, duodenal obstruction). ### Correct Management Algorithm ```mermaid flowchart TD A[Distal CBD obstruction]:::outcome --> B{Benign or malignant?}:::decision B -->|Benign| C[ERCP + sphincterotomy ± stent]:::action B -->|Malignant| D[Assess resectability]:::decision C --> E{Success?}:::decision E -->|Yes| F[Stent management/follow-up]:::outcome E -->|No| G[PTC or surgery]:::action D -->|Resectable| H[Surgical resection]:::action D -->|Unresectable| I[Palliative stent ERCP/PTC]:::action ``` **Mnemonic:** **ERCP-First** — **E**ndoscopy is first-line, **R**eserve surgery, **C**holedochoduodenostomy for failed **P**ercutaneous/**E**ndoscopic **C**are. [cite:Sabiston Textbook of Surgery Ch 54]